These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 12571812)

  • 21. Pemetrexed disodium: a novel antifolate clinically active against multiple solid tumors.
    Hanauske AR; Chen V; Paoletti P; Niyikiza C
    Oncologist; 2001; 6(4):363-73. PubMed ID: 11524555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MTA, A Novel Multitargeted Antifolate: from preclinical to phase I and beyond. Proceedings of a meeting. Ixtapa, Mexico, March 13-15, 1998.
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):1-110. PubMed ID: 10610578
    [No Abstract]   [Full Text] [Related]  

  • 23. Pemetrexed (Alimta): a promising new agent for the treatment of breast cancer.
    Calvert H
    Semin Oncol; 2003 Apr; 30(2 Suppl 3):2-5. PubMed ID: 12722017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pemetrexed safety and dosing strategy.
    Niyikiza C; Hanauske AR; Rusthoven JJ; Calvert AH; Allen R; Paoletti P; Bunn PA
    Semin Oncol; 2002 Dec; 29(6 Suppl 18):24-9. PubMed ID: 12571807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pemetrexed disodium combined with oxaliplatin, SN38, or 5-fluorouracil, based on the quantitation of drug interactions in human HT29 colon cancer cells.
    Raymond E; Louvet C; Tournigand C; Coudray AM; Faivre S; De Gramont A; Gespach C
    Int J Oncol; 2002 Aug; 21(2):361-7. PubMed ID: 12118332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The emerging role of pemetrexed (Alimta) and gemcitabine in non-small cell lung cancer.
    Le Chevalier T
    Semin Oncol; 2003 Aug; 30(4 Suppl 10):37-44. PubMed ID: 12947960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pemetrexed for diffuse malignant pleural mesothelioma.
    Manegold C; Aisner J
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):30-5. PubMed ID: 12023790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New data integrating multitargeted antifolates into treatment of first-line and relapsed non-small-cell lung cancer.
    Scagliotti GV; Selvaggi G
    Clin Lung Cancer; 2008; 9 Suppl 3():S122-8. PubMed ID: 19419926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A predictive model for evaluating responsiveness to pemetrexed treatment in patients with advanced colorectal cancer.
    Wu XY; Huang XE; Cao J; Shi L; Xu X; Qian ZY
    Asian Pac J Cancer Prev; 2014; 15(14):5941-4. PubMed ID: 25081726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pemetrexed (Alimta): a novel multitargeted antifolate agent.
    Adjei AA
    Expert Rev Anticancer Ther; 2003 Apr; 3(2):145-56. PubMed ID: 12722874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brief communication: use of the multitargeted antifolate pemetrexed (Alimta) in genitourinary cancer.
    Misset JL
    Semin Oncol; 2002 Feb; 29(1 Suppl 3):36-9. PubMed ID: 11894006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of Pemetrexed (Alimta , LY231514) in lung cancer therapy.
    Molina JR; Adjei AA
    Clin Lung Cancer; 2003 Jul; 5(1):21-7. PubMed ID: 14596699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pemetrexed: a novel antifolate agent enters clinical practice.
    Kut V; Patel JD; Argiris A
    Expert Rev Anticancer Ther; 2004 Aug; 4(4):511-22. PubMed ID: 15270656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased anticancer activity of the thymidylate synthase inhibitor BGC9331 combined with the topoisomerase I inhibitor SN-38 in human colorectal and breast cancer cells: induction of apoptosis and ROCK cleavage through caspase-3-dependent and -independent mechanisms.
    Coudray AM; Louvet C; Kornprobst M; Raymond E; André T; Tournigand C; Faivre S; De Gramont A; Larsen AK; Gespach C
    Int J Oncol; 2005 Aug; 27(2):553-61. PubMed ID: 16010439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pemetrexed plus carboplatin or oxaliplatin in advanced non-small cell lung cancer.
    Scagliotti GV
    Semin Oncol; 2005 Apr; 32(2 Suppl 2):S5-8. PubMed ID: 15818537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pemetrexed and oxaliplatin for metastatic colorectal cancer: results of a phase I Mayo Cancer Center Research Consortium trial, MC0248.
    Alberts SR; Kim GP; Mahoney MR; Gornet MK; Rubin J; Ames M; Goetz MP; Weinshilboum RM; Nicol SJ; Goldberg RM
    Clin Colorectal Cancer; 2007 Jul; 6(8):572-7. PubMed ID: 17681103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pemetrexed in malignant pleural mesothelioma.
    Gatzemeier U
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):26-31. PubMed ID: 15655933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MTA, a novel multitargeted antifolate, from preclinical to phase I and beyond: summary and conclusions.
    Calvert H
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):105-8. PubMed ID: 10598564
    [No Abstract]   [Full Text] [Related]  

  • 39. Pemetrexed in front-line chemotherapy for advanced non-small-cell lung cancer.
    Scagliotti GV; Novello S; Crino L; Rosell R
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):32-7. PubMed ID: 15655934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gemcitabine and Pemetrexed disodium in treating breast cancer.
    Adjei AA
    Oncology (Williston Park); 2001 Feb; 15(2 Suppl 3):34-7. PubMed ID: 11252887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.